Latest Market Access News

1414 Degrees has inked a letter of intent with South Korea’s JR Energy Solution to jointly develop and scale battery cells using its SiNTL silicon anode technology, targeting defence, UAV, space, and robotics markets.

NZX Limited reported a robust first half of 2026 with operating earnings up 9.4% and net profit rising 18%. The exchange strengthened its funds management and wealth administration arms, relaunched equity derivatives, and declared a higher interim dividend. A new CEO is set to take the helm in September.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

OD6 Metals is moving to list its shares on the US OTCQB Venture Market to tap growing North American investor interest and highlight its high-grade Quinn Fluorspar Project in Nevada, a critical mineral asset in a 100% import-dependent US market.

Xenitra’s Hong Kong subsidiary Fukang has inked a three-year A$5 million procurement framework for specialised medical nutrition products, broadening its foothold beyond OTC medicines in China’s booming healthcare market.

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

Steadfast Group's consortium reconfirms $6 per share cash offer, extending exclusivity to 21 August amid final due diligence.

Osmond Resources has reinforced the continuity of high-grade critical minerals at its Orión project in Spain, with drill hole SOR-07A delivering promising assay results. The company is on track to release its maiden Mineral Resource Estimate and Scoping Study by Q3 2026, supported by robust mineral processing testwork and a new Frankfurt listing.

Austco Healthcare has completed the $2.24 million acquisition of Medical Communications Systems, transitioning its long-term South Australian reseller into a direct sales operation to deepen market engagement.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

Cauldron Energy has begun trading on the US OTCQB market, broadening access to American investors without issuing new shares. This move taps into growing US demand for uranium, positioning Cauldron as a potential supplier from its Yanrey Uranium Project.

KTEK Aerosystems has obtained a key export licence from the Netherlands, enabling it to ship components to its US facility for assembly and delivery. This milestone solidifies the company’s trans-Atlantic supply chain and supports its targeted September delivery restart.